Viroclinics Biosciences Competitors and Similar CompaniesClear all

Viroclinics Biosciences's competitors and similar companies include R-Biopharm, Gilead Sciences, Clinical Trials of Texas and iNtRON Biotechnology.

	Viroclinics Biosciences Viroclinics Biosciences (Viroclinics-DDL) is a diagnostic and clinical trial operation service company.	R-Biopharm R-Biopharm is a company that provides products and solutions in the field of analytics.	Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.	Clinical Trials of Texas Clinical Trials of Texas (CTT, also known as Flourish Research - San Antonio) is a clinical research organization.	iNtRON Biotechnology iNtRON Biotechnology is a research and development company developing bio-drugs and conducting clinical studies.
Founding Date	Founding Date 2001	Founding Date 1988	Founding Date 1987	Founding Date 2001	Founding Date 1999
Type	Type Subsidiary	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Manufacturing & Industrial biotech clinical research pharma	Tags Business Products & Services biotech clinical research pharma	Tags Manufacturing & Industrial biotech clinical research drug development pharma	Tags Healthcare biotech clinical research pharma	Tags Manufacturing & Industrial biotech clinical research pharma
Locations	Locations Rotterdam, NL HQ	Locations Darmstadt, DE HQ	Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more	Locations San Antonio, US HQ	Locations Seongnam-si, KR HQ
Employees	Employees 991% decrease	Employees 1,400	Employees 18,0006% increase	Employees 642% decrease	Employees 76
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $29.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩6.4b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $6.2b (FY, 2025)	Cost of goods N/A	Cost of goods ₩1.5b (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $23.2b (FY, 2025)	Gross profit N/A	Gross profit ₩5b (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income $8.5b (FY, 2025)	Net income N/A	Net income (₩2.6b) (FY, 2024)
Operating ⚠
Countries	Countries N/A	Countries 122 (Sep, 2023)	Countries 35 (FY, 2021)	Countries N/A	Countries N/A
Products	Products N/A	Products 960 (Sep, 2023)	Products 21 (FY, 2021)	Products N/A	Products N/A